Remedor Biomed Ltd.
PrivateLast Round
Grant
Jun 18, 2015
Total Funding Raised
$750,000
Company Overview
Remedor Biomed Ltd. is a biopharmaceutical company that develops topical biologic therapies for the treatment of complex skin wounds, including diabetic foot ulcers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Remedor Biomed Ltd. Comparables
Compare Remedor Biomed Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ElkosRx, LLC | 82% | |
| Aurealis Therapeutics | 78% | |
| SynDermix AG | 78% |
Remedor Biomed Ltd. Funding Rounds
Historical fundraising activity
Remedor Biomed Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Accelerator |
| BIRD Foundation | Grant |
| Next Generation Technology (NGT3VC) | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2015
Received funding from the BIRD Foundation.
Remedor Biomed Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Remedor Biomed Ltd.'s valuation, stock price, and market status.
Is Remedor Biomed Ltd. a public or private company?
Remedor Biomed Ltd. is a private company.
What is the current stock price of Remedor Biomed Ltd.?
Remedor Biomed Ltd. is a private company, so its shares have no public market price. Caplight tracks Remedor Biomed Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Remedor Biomed Ltd. worth (valuation)?
Valuation information for Remedor Biomed Ltd. is not publicly available.
Can I buy Remedor Biomed Ltd. stock?
Remedor Biomed Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Remedor Biomed Ltd.'s last funding round?
Remedor Biomed Ltd.'s most recent funding round was Grant on June 18, 2015.
Who are the main investors in Remedor Biomed Ltd.?
Key investors in Remedor Biomed Ltd. include Next Generation Technology (NGT3VC).
Will Remedor Biomed Ltd. IPO soon?
No public IPO plans have been announced for Remedor Biomed Ltd..
How can I track Remedor Biomed Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Remedor Biomed Ltd.'s shares on secondary markets.